Alzheimer's
Do you want to receive a message when there is new research about Alzheimer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence that explains what was examined — and you'll receive a notification as soon as there is new research about Alzheimer's. View what Premium costs.
Publications and studies (3591)
- Ditan Decoction alleviates glutamate excitotoxicity in an Aβ-induced Alzheimer's disease-like model through the regulation of ERBB2/PI3K/AKT signaling pathway. (2026/12/06) ♡
- Epigenetic changes associated with the progression of prion disease in Syrian hamsters (Mesocricetus auratus). (2026/12/01) ♡
- Broussochalcone A alleviates cognitive impairment in scopolamine-induced mice as a potent β-amyloid aggregation inhibitor and changes blood and brain metabolite profiles. (2026/11/15) ♡
- AI-assisted integrative framework combining microarray data analysis and cerebrospinal fluid pharmacology for revealing molecular mechanism in Alzheimer's disease: A case study of Psoraleae Fructus. (2026/10/15) ♡
- Mitochondria-associated endoplasmic reticulum membranes and calcium ion exchange: A novel direction for aging and neurodegenerative diseases. (2026/10/01) ♡
- Early and sustained Intervention with YKB Modulates the Cerebro-Retinal-Synaptic Network to Ameliorate Memory Deficits in Alzheimer's Disease. (2026/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural monomer compounds in neurodegenerative diseases: Targeting ferroptosis and neuroinflammation. (2026/09/13) ♡
- Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment. (2026/09/08) ♡
- Progression to Dementia in Very Late-Onset Schizophrenia-Like Psychosis Stratified by Alzheimer's Disease and Lewy Body Disease Biomarkers: A Retrospective Cohort Study. (2026/09/01) ♡
- When copper turns killer: Decoding copper dyshomeostasis and cuproptosis in neurodegenerative pathogenesis and precision metal interventions. (2026/09/01) ♡
- Deep learning-based cognitive impairment brain imaging analysis: New methods, new technologies, and new paradigms. (2026/09/01) ♡
- Neuromodulation techniques targeting neurotransmitter dysfunction: Innovation in treatments for Alzheimer's disease. (2026/09/01) ♡
- Unveiling the multi-target mechanisms of Zuo Gui Wan in Alzheimer's disease: An integrated study combining network pharmacology, Mendelian Randomization, and molecular docking. (2026/09/01) ♡
- Huang-Lian-Jie-Du Decoction alleviates cognitive deficits in Alzheimer's disease via aromatase-mediated regulation of Aβ metabolism. (2026/09/01) ♡
- Atrazine induces Alzheimer's disease-like neurotoxicity by targeting SDHB and disrupting synaptic function: An integrated bioinformatic and in vivo study. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Stable Isotope-Resolved Metabolomics in Elucidating Mitochondrial Metabolic Reprogramming and Therapeutic Targets. (2026/09/01) ♡
- Robust Inference With Ghostknockoffs in Genome-Wide Association Studies With Sample Relatedness. (2026/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of Intravenously Administered Plasma from Exercise-Trained Donors on Mitochondrial Respiration in a Rat Model of Alzheimer's Disease. (2026/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Replay Letter to: 'Loneliness as an Interface Between Alzheimer's Disease and Suicidal Behaviour: A Methodological Concern'. (2026/09/01) ♡
- [Association between 473 gut microbiota and Alzheimer's disease: a Mendelian randomization mediation analysis of 233 circulating metabolites]. (2026/08/20) ♡
- Rational Design of Multifunctional Tacrine Derivatives as Candidates for the Treatment of Alzheimer and Parkinson Diseases. (2026/08/14) ♡
- In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging. (2026/08/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myokines, Microbiota, and Neuroinflammation: Physical Activity Modulates the Gut-Brain Axis. (2026/08/11) ♡
- Deficits in the knowledge of social norms and their correlates in Alzheimer's disease. (2026/08/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exosome-based nanomedicine for neurological disorders: mechanisms, engineering, and therapeutic potential. (2026/08/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Luteolin and neurodegenerative disease modulation: linking molecular mechanisms, neurotransmission, and pharmacokinetics. (2026/08/11) ♡
- Effects of damaged astrocytes on DNA damage and repair in human neurons: Implications for Alzheimer's disease. (2026/08/11) ♡
- Individual alpha peak frequency tracks Alzheimer's disease progression: A longitudinal pilot study. (2026/08/11) ♡
- Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging. (2026/08/11) ♡
- Integrative transcriptomic and genetic analysis implicates fatty acid metabolic reprogramming in perivascular macrophages in Alzheimer's disease. (2026/08/11) ♡
- Voice Disorders as Early Biomarkers of Cognitive Decline. (2026/08/11) ♡
- Intellectual disabilities and risk of dementia: A Korean population-based cohort study. (2026/08/10) ♡
- Bis-hydrophobic 5-(1,2-dithiolan-3-yl)pentanamide budding leads targeting brain sigma-1 receptors. (2026/08/10) ♡
- Brain-seeded 42-residue amyloid-β fibrils that resemble fibrils directly extracted from Alzheimer's disease brain tissue. (2026/08/10) ♡
- Opposing kinase signaling may underlie the inverse relationship between cancer and Alzheimer's disease. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dramatic sex differences leading to different brain disease presentation: The requirement for sex-specific medications with ADNP/davunetide as a case study. (2026/08/10) ♡
- Metabolic Vulnerability Indices and Alzheimer's Disease Risk: A Prospective Analysis of the UK Biobank Cohort. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Establishing causality for protein lactylation in Alzheimer's disease: site validation, evidence standards, and experimental priorities. (2026/08/10) ♡
- Let-7d-5p improves mouse cognitive function by targeting bach1 in Alzheimer's disease. (2026/08/10) ♡
- SIK2-P300 axis Orchestrates the metabolic reprogramming and Immunological functions in microglia of Alzheimer's disease mice via a dual modulation of lactylation and Acetylation: An epigenetic Perspective. (2026/08/10) ♡
- Amyloidogenic amylin signaling links diabetes to dementia pathogenesis. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sex-sensitive serotonergic signaling in psychedelic pharmacology. (2026/08/10) ♡
- Liquid-liquid phase-separated tau colocalizes with and stabilizes Aβ oligomers. (2026/08/10) ♡
- High-frequency visual stimulation can increase medial temporal lobe ripple oscillation density. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Amino Acid-Neurodegeneration Axis: Excitotoxicity and Oxidative Stress as Context-Dependent Amplifiers of Metabolic Dysfunction. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rational drug design for Alzheimer's disease: from approved therapies to next-generation clinical candidates and AI-guided innovation. (2026/08/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Osteoarthritis management through medical reversal: Glucosamine, Alzheimer's disease risk, and long-term outcomes after arthroscopic partial meniscectomy. (2026/08/10) ♡
- Spatial-Spectral Fusion Enables Drug Repositioning by Capturing Indirect and Long-Range Associations in Biological Networks. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities. (2026/08/10) ♡
- Factors associated with selection of total hip arthroplasty versus hemiarthroplasty for femoral neck fracture in older adults: a nationwide analysis of 99,084 cases. (2026/08/10) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.